All stock lists
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
Healthcare · Biotechnology
0.19-0.02 (-8.12%)
Insider Score
––Not scored
TCRX Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
TCRX analyst forecast
TCRX analyst consensus
Hold3 ratings
Buy 0 Hold 3 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
TCRX 12-month price target
$1.00+442.9% upsideaverage of 1 firm
$1.00High
$1.00Low
Best analysts covering TCRX
- HC Wainwright & Co.36%success rate · 14 calls
- Needham0%success rate · 7 calls
- Wedbush0%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
TCRX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-09-08 |
| H.C. Wainwright | — | $1.00 | +174.6% | — | 2026-09-08 | |
| — | Wedbush | Neutral | — | — | Downgraded | 2026-09-03 |
| — | Needham | Hold | — | — | Downgraded | 2026-09-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-12 |
| — | Needham | Buy | — | — | Reiterated | 2026-06-23 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-06-23 |
| — | Wedbush | Outperform | — | — | Reiterated | 2026-03-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-11-13 |
| — | Needham | Buy | — | — | Reiterated | 2025-11-04 |
| — | BTIG | Neutral | — | — | Downgraded | 2025-11-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-07 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-08 |
| — | Barclays | Overweight | — | — | Reiterated | 2025-03-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-06 |
| — | Needham | Buy | — | — | Reiterated | 2025-03-05 |
| — | Needham | Buy | — | — | Reiterated | 2024-12-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-15 |
| — | Needham | Buy | — | — | Reiterated | 2024-11-12 |
| — | Needham | Buy | — | — | Reiterated | 2024-11-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-13 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-08-13 |
| — | Needham | Buy | — | — | Reiterated | 2024-08-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-06-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-14 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-13 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-04-23 |
| — | Barclays | Overweight | — | — | Reiterated | 2024-03-07 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-07 |
| — | Wedbush | Outperform | — | — | Reiterated | 2024-02-01 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-14 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-09 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2022-05-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2021-12-16 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2021-08-13 |
| — | Jefferies | Buy | — | — | Reiterated | 2021-08-10 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2021-08-10 |
TCRX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-04 | -0.27 | -0.18 | $2.4M | $2.6M |
| 2026-05-06 | -0.22 | -0.22 | $2.5M | $982K |
| 2026-08-12 | -0.25 | -0.23 | $1.9M | $1.1M |
| 2026-11-11 | -0.18 | 0.00 | $459K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.